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Acute injuries of the kidney or lung each represent serious,
complex clinical problems, and their combination drastically
decreases patient survival. However, detailed understanding
of interactions between these two organs is scarce.
To evaluate this further, we used the folic acid (FA) and
myohemoglobinuria models of acute kidney injury (AKI)
together with Pseudomonas aeruginosa inhalation to study
kidney–lung cross-talk in mice during acute kidney and lung
injury. Subgroups of mice received antineutrophil antibody
or platelet-depleting serum to assess the role of neutrophil
and platelets, respectively. AKI by itself did not cause
clinically relevant acute lung injury. Pneumonia was
neutrophil dependent, whereas pneumonia-induced AKI was
platelet dependent. AKI attenuated pulmonary neutrophil
recruitment and worsened pneumonia. Mice with AKI had
lower oxygen saturations and greater bacterial load than
mice without. Neutrophils isolated from mice with
FA-induced AKI also had impaired transmigration and
F-actin polymerization in vitro. Thus, during acute kidney
and pneumonia-induced lung injury, clinically relevant
kidney–lung interactions are both neutrophil and platelet
dependent.
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Both acute kidney injury (AKI) and acute lung injury (ALI)
remain frequent and serious challenges in critically ill
patients. Survival decreases drastically when AKI and ALI
occur together.1,2 The development of AKI in the setting of
ALI carries an in-hospital mortality rate of 58%, compared
with 28% in ALI patients without AKI.2 Our current
understanding is that kidney–lung cross-talk has a major
role in worsening outcomes. However, knowledge regarding
the underlying mechanisms is incomplete at best, and at
times even controversial. Experimental studies have lead
investigators to propose various mechanisms, including
release of soluble inflammatory mediators, apoptosis, and
leukocyte recruitment.
AKI leads to a systemic release of various chemokines and
cytokines, as well as increased expression of proinflammatory
genes in healthy lungs.3,4 AKI further activates the proapopto-
tic transcriptome5 and subsequently causes endothelial cell
apotosis, even in healthy lung tissue.6 The fundamental role of
platelets and leukocytes in ALI, and in particular neutrophils,
has been well established in different experimental models.7,8
However, the relevance of neutrophils or platelets for
kidney–lung interactions remains unknown despite recent
research efforts. Rat models of both bilateral renal ischemia–
reperfusion and bilateral nephrectomy have demonstrated
significant recruitment of neutrophils into healthy lungs.3,9
Contrary to these findings, we have shown that AKI protects
from HCl-induced ALI by attenuating neutrophil recruitment
into inflamed lungs.10 We have also provided evidence that
uremic neutrophils, but not normal neutrophils in a uremic
milieu, fail to recruit into the inflamed lung.10
Several clinical and experimental studies have revealed
deleterious effects of ALI on renal function. However, most
mechanisms identified to date are related to mechanical
ventilation rather than to ALI itself. Lung-protective ventila-
tion, as opposed to conventional ventilation, not only
reduced mortality from severe ALI but also reduced the rate
of AKI.11,12 The changes in intrathoracic pressure associated
with mechanical ventilation alters systemic and, subse-
quently, renal hemodynamics, leading to a decrease in
glomerular filtration rate, free water clearance, urinary
Na excretion, and creatinine clearance.13–15 Moreover,
mechanical ventilation can induce a so-called biotrauma
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and subsequent systemic release of proinflammatory cyto-
kines, which correlate with the degree of remote organ
failure.12,16 Mechanical ventilation can further lead to
apoptosis of renal epithelial cells.17 However, little is known
about the effects of ALI itself on remote organ function and
the underlying mechanisms. In a recent clinical study with
more than 1800 patients hospitalized for community
acquired pneumonia, 34% of the patients developed AKI.18
AKI was associated with a significant increase in the risk of
death out to 1 year. Patients who developed AKI with or
without sepsis displayed significantly higher proinflamma-
tory markers and coagulation activation.
The paucity of data regarding the direct effects of ALI on
remote organs, as well as the controversy surrounding the
effects of AKI on pulmonary functions, prompted us to
conduct the following study. We have used two murine
models of AKI together with bacterial ALI (Pseudomonas
aeruginosa pneumonia) to further unravel kidney–lung
interactions during AKI and pneumonia, as well as their
underlying mechanisms (Figure 1a).
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Figure 1 | Two-hit model of acute kidney injury (AKI) and pneumonia to study kidney–lung cross-talk during AKI and acute lung injury.
(a) At t¼ 0h, mice receive intraperitoneal (i.p.) injections of folic acid (FA) or NaHCO3. After 24h, mice are placed in an airtight chamber to inhale
aerosolized Pseudomonas aeruginosa or 0.9% NaCl. After 48h, vital signs are observed and mice are then anesthetized to collect blood samples
and harvest organs. This design results in four different experimental groups (Figure 1): mice with control injection and sham inhalation
(group 1), mice with AKI and sham inhalation (group 2), mice with control injection and pneumonia (group 3), and mice with AKI and
pneumonia (group 4). (b) Both i.p. injection of FA and intramuscular (i.m.) injection of glycerol induced significant AKI, RIFLE-R (FA) and RIFLE-I/F
(glycerol), respectively. Relative changes in plasma creatinine and cystatin C (c) were very similar. (d) Inhalation of P. aeruginosa leads to a
significant increase in plasma interleukin-6 (IL-6) levels. (e) FA-induced AKI itself only leads to a small, nonsignificant rise in plasma IL-6 levels.
Preexisting AKI does not affect plasma IL-6 levels during pneumonia. *Po0.05 versus sham/control experiments. RIFLE; Risk, Injury, Failure, Loss,
End-stage.
634 Kidney International (2011) 80, 633–644
or ig ina l a r t i c l e K Singbartl et al.: Acute kidney injury and pneumonia
RESULTS
Intraperitoneal injection of folic acid and intramuscular
injection of glycerol cause AKI
Both intraperitoneal injection of folic acid and intramuscular
injection of glycerol, via subsequent myohemoglobinuria,19,20
cause AKI within 24 h after injection, as evidenced by significant
and corresponding increases in plasma creatinine (Figure 1b)
and cystatin C (Figure 1c). The degree of AKI in both models
is equivalent to the clinical stage Risk, Injury, Failure, Loss,
End-stage-R/I.21
Preexisting AKI does not affect systemic inflammation
during pneumonia
Inhalation of P. aeruginosa leads to a significant increase
in circulating interleukin-6 (IL-6), indicating substantial
inflammation (Figure 1d). Plasma IL-6 levels during
pneumonia are also significantly elevated with preexisting
AKI (Figure 1e). The preexistence of AKI does not affect the
plasma levels of IL-6 during pneumonia. Mice with folic acid
(FA)-induced AKI display a nonsignificant trend toward
increased IL-6 plasma levels (Figure 1e).
Severity of P. aeruginosa-induced pneumonia depends on
neutrophils
Inhalation of P. aeruginosa leads to clinically relevant
pneumonia and pulmonary inflammation in mice at 24 h,
as evidenced by decreased pulse oxymetric oxygen saturation,
isolation of P. aeruginosa colony-forming units from lung
homogenates, and pulmonary recruitment of neutrophils
(Figure 2a–c). Neutrophil depletion before induction of
pneumonia results in more severe pneumonia with worse
oxygenation and higher bacterial load (Figure 2d and e).
AKI does not induce clinically relevant ALI but worsens
preexisting pneumonia
Similar to our models of renal ischemia–reperfusion
and bilateral nephrectomy, FA-induced AKI itself (group
2: AKIþ sham versus group 1: controlþ sham) does
not impair oxygenation (Figure 3a), does not lead to
significant recruitment of neutrophils into the lung
(Figure 3e), and does not cause overt histological changes
in the lung (Figure 4c).
Preexisting AKI, however, significantly worsens bacterial
pneumonia. Mice with FA-induced AKI demonstrate sig-
nificantly reduced oxygenation (Figure 3a) and higher
bacterial load after P. aeruginosa inhalation than mice
without AKI (Figure 3c). Moreover, FA-induced AKI impairs
pulmonary neutrophil recruitment during bacterial inflam-
mation, as indicated by reduced myeloperoxidase (MPO)
in lung homogenates (Figure 3e). The effects of AKI appear
to be independent of the model used. After inhalation
of P. aeruginosa, glycerol-induced myohemoglobinuric
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Figure 2 | Pseudomonas aeruginosa inhalation causes pneumonia in a neutrophil-dependent manner. (a) P. aeruginosa colony-
forming units (CFUs) can be detected in lung homogenates after inhalation of bacteria but not of 0.9% NaCl. (b) Compared with sham
inhalation, P. aeruginosa inhalation leads to impaired oxygenation, as demonstrated by reduced pulse oxymetric oxygen saturation (SpO2).
(c) P. aeruginosa inhalation gives rise to pulmonary recruitment of neutrophils, as measured by an increase in lung myeloperoxidase (MPO)
activity. (d) Antibody (a-GR-1)-mediated neutrophil depletion before P. aeruginosa inhalation further impairs oxygenation when compared
with control injections. (e) At 24 h after inhalation, neutrophil-depleted (a-GR-1-treated) mice reveal larger numbers of P. aeruginosa CFUs
in lung homogenates than mice treated with a control antibody.
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AKI also further decreases pulse oxymetric oxygen
saturation (Figure 3b), increases the pulmonary bacterial
load (Figure 3d), and impairs neutrophil recruitment
(Figure 3f).
As both oxygenation and bacterial load after P. aeruginosa
inhalation are neutrophil dependent, the data provide
evidence for neutrophil-dependent deterioration of pneu-
monia during AKI. Interestingly, histological evidence of
pulmonary inflammation, for example, interstitial edema
and cell infiltration, appears to be less pronounced with
preexisting AKI (Figure 4g, group 4: AKIþ pneumonia) than
without it (Figure 4e, group 3: controlþ pneumonia).
The amount of P. aeruginosa-positive blood cultures
was not statistically different between mice with and
without preexisting FA-induced AKI (group 3: pneumoniaþ
control¼ 4/20 versus group 4: AKIþ pneumonia¼ 5/20).
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Figure 3 |Acute kidney injury (AKI) worsens bacterial pneumonia. (a) Compared with mice without AKI (group 1: AKIþ sham), folic acid
(FA)-induced AKI (group 2: AKIþ sham) itself does not affect oxygenation in mice with sham inhalation. However, preexisting AKI worsens
oxygenation in mice with Pseudomonas aeruginosa inhalation (group 3: controlþpneumonia versus group 4: AKIþpneumonia). (b) Mice
with preexisting AKI display a significantly greater number of P. aeruginosa colony-forming units (CFUs) in lung homogenates after
inhalation (group 4: AKIþpneumonia) than mice without AKI (group 3: pneumoniaþ control). (c) Preexisting AKI itself (group 2: AKIþ sham
versus group 1: controlþ sham) does not cause significant increase in lung myeloperoxidase (MPO), indicating no substantial influx of
neutrophils into lungs. Preexisting AKI, however, significantly decreases lung MPO in the setting of bacterial pneumonia (group 3:
controlþpneumonia versus group 4: AKIþpneumonia), indicating attenuated recruitment of neutrophils into the lung. Compared with FA-
induced AKI, glycerol-induced myohemoglobinuric AKI had similar effects on oxygenation (d), bacterial load in the lung (e), and pulmonary
neutrophil recruitment (f). * and # indicate Po0.05 versus sham and control experiments, respectively.
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Neutrophils from mice with FA-induced AKI show impaired
transmigration and F-actin polymerization in vitro
Neutrophils from mice with FA-induced AKI reveal
a markedly reduced in vitro transmigration toward
N-formylmethionyl-leucyl-phenylalanine (fMLP) compared
with neutrophils from control mice (Figure 5a). In the
absence of fMLP stimulation, neutrophils from mice with
FA-induced AKI do not migrate through the transwell similar
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Group 4Group 4
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Figure 4 |Histological analysis of representative hematoxylin and eosin-stained tissue sections from a two-hit model of acute
kidney injury and bacterial pneumonia ( 40). (a) Unremarkable lung histology in mice after control injection and sham inhalation
(group 1). (b) Normal kidney histology in mice after control injection and sham inhalation (group 1). (c) Intraperitoneal (i.p.) injection of
folic acid (FA) with sham inhalation does not induce histological damage in the lung (group 2). (d) Severe histological damage occurs
in kidneys after i.p. injection of FA (and sham inhalation, group 2), in particular, flattening of tubule epithelia (acute tubular necrosis).
(e) Inhalation of Pseudomonas aeruginosa (group 3: controlþpneumonia) leads to severe histological damage, including diffuse alveolar
damage, neutrophil influx, and interstitial edema. (f) Inhalation of P. aeruginosa (group 3) only causes mild histological changes in
the kidneys, characterized by hyperemia and tubular edema. (g) Combined i.p. injection of FA and inhalation of P. aeruginosa (group 4)
gives rise to alveolar damage consistent with bacterial pneumonia but milder than that observed in ‘simple pneumonia’ (see e for
comparison). Here, cellular infiltrates and interstitial edema seem markedly decreased. (h) Histological damage in kidneys after
combined i.p. injection of FA and inhalation of P. aeruginosa (group 4) is characterized by both tubular damage typical for FA toxicity
and pneumonia-related hyperemia.
Kidney International (2011) 80, 633–644 637
K Singbartl et al.: Acute kidney injury and pneumonia o r ig ina l a r t i c l e
to neutrophils from control mice (data not shown). This
suggests that neutrophils from mice with FA-induced AKI are
not in an activated state, which could have rendered them
unresponsive to the stimulus.
To determine whether the abnormal migration of FA-
treated neutrophils was related to abnormal cytoskeleton
rearrangement, we examined F-actin reorganization in
neutrophils stimulated with fMLP on fibrinogen-coated
slides. Neutrophils from control mice display one short
and narrow lamellipodia of F-actin at one pole of the cell
(Figure 5b). In contrast, neutrophils from mice with
FA-induced AKI show a prominent and large protrusion of
F-actin (Figure 5b), as evidenced by a significant increase in
surface area of F-actin compared with that of neutrophils
from control mice (Figure 5c). In addition, some neutro-
phils from mice with FA-induced AKI cells exhibited two
protrusions of F-actin.
Pneumonia-induced AKI is platelet dependent
P. aeruginosa pneumonia induces AKI, equivalent to the
clinical stage Risk, Injury, Failure, Loss, End-stage-R,21 as
demonstrated by significant increases in plasma creatinine
(Figure 6a) and cystatin C (Figure 6b). The significant rise in
urinary neutrophil gelatinase-associated lipocalin provides
strong evidence for direct tubular injury during pneumonia
(Figure 6c). Moreover, unchanged pulse distension22,23
during pneumonia makes significant changes in systemic
hemodynamics following inhalation of P. aeruginosa unlikely
(Figure 6d), further substantiating the notion of direct kidney
injury in our pneumonia model.
Contrary to our findings in the lung, pneumonia does not
lead to neutrophil influx into the kidneys, as indicated by
histology (Figure 4f) and unchanged renal MPO (Figure 6e).
Moreover, pretreatment with a neutrophil-depleting antibody
does not affect the development of pneumonia-induced AKI
(Figure 6f).
Periodic acid-Schiff staining of kidney sections shows
brush-border defects of tubular epithelial cells in both
pneumonia-induced AKI (Figure 7a) and FA-induced AKI
(Figure 7b). Although terminal deoxynucleotidyl transferase
20-deoxyuridine 50-triphosphate nick-end labeling staining
reveals only very mild signs of apoptosis in pneumonia-
induced AKI (Figure 6c), there is evidence for overt apoptosis
in FA-induced AKI (Figure 6d).
Prompted by recent findings about pronounced hemos-
tasis activation in patients with AKI following community-
acquired pneumonia,18 we next examined the role of
platelets in pneumonia-induced AKI. Mice pretreated with
antiplatelet serum demonstrate lower pulse oxymetric oxygen
saturation (Figure 8a) and higher pulmonary bacterial
load (Figure 8b) after P. aeruginosa inhalation, compared
with mice pretreated with control serum, indicating overall
worsening of pneumonia. However, platelet-depleted mice
display lower plasma creatinine concentrations after
P. aeruginosa inhalation, indicating a better-preserved renal
function.
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Figure 5 |Neutrophils from mice with folic acid (FA)-induced
acute kidney injury (AKI) show impaired transmigration and
F-actin arrangement in vitro. (a) Neutrophils from mice with
FA-induced AKI show significantly reduced transmigration toward
N-formylmethionyl-leucyl-phenylalanine (fMLP). (b) F-actin structures
in Z series of fluorescence images: neutrophils from vehicle-treated
mice exhibited one short and narrow lamellipodia of F-actin at
one pole of the cell. In contrast, FA-treated neutrophils were
characterized by a prominent and large protrusion of F-actin. (c) The
significant increase in surface area of F-actin in neutrophils from
mice with FA-induced AKI suggests that these neutrophils cannot
limit F-actin formation. The black-and-white pictures represent
phase-contrast images of stimulated cells. The images are one
x–y view of the Z series analyzed by deconvolution in Volocity.
Histograms reflect surface area of lamellipodia (n¼ 3 mice,
40 cells/mouse). Arrows indicate F-actin protrusions. Scale
bar¼ 5mm. *Po0.05 versus sham/control experiments. Fg, slide
coating of fibrinogen; PMN, polymorphonuclear fibrinogen.
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DISCUSSION
Both AKI and ALI significantly reduce survival, particularly
when they occur together. Nevertheless, only limited, and
at times even controversial, information is available regarding
kidney–lung cross-talk under pathological conditions. More-
over, there are no data regarding the mechanisms of
kidney–lung interactions during bacterial ALI and AKI. A
better understanding is of utmost importance, as pneumonia
represents the most frequent cause of sepsis, which, in turn, is
the leading cause of AKI in critically ill patients.24,25
Using a murine two-hit model of AKI and bacterial
pneumonia, we show that FA-induced AKI itself has no
clinically overt effect on healthy lungs, as indicated by
unchanged oxygenation 48 h after induction of AKI.
Similarly, lung histology is largely unaffected by FA-induced
AKI, although there is a slight trend toward increased lung
MPO activity, indicating mild neutrophil influx. Preexisting
AKI, however, attenuates pulmonary neutrophil recruitment
during pneumonia, but does not affect plasma IL-6 levels
during pneumonia. AKI appears to increase bacterial
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Figure 6 |Bacterial pneumonia causes acute kidney injury. (a) Inhalation of Pseudomonas aeruginosa, but not sham inhalation, gives
rise to a significant elevation in plasma creatinine. (b) Compared with sham inhalation, inhalation of P. aeruginosa also increases plasma
cystatin C concentrations in mice. (c) Significant increases in urinary neutrophil gelatinase-associated lipocalin (NGAL) concentrations after
inhalation of P. aeruginosa indicate significant tubular injury in these mice compared with mice with sham inhalation. (d) Similar pulse
distension in mice with sham inhalation and mice with earlier P. aeruginosa inhalation suggests comparable systemic hemodynamics
between these groups. (e) Inhalation of P. aeruginosa does not induce neutrophil recruitment into the kidneys, as evidenced by unchanged
renal myeloperoxidase (MPO) levels between mice with sham inhalation and mice with earlier P. aeruginosa inhalation. (f) Neutrophil
depletion with anti-GR1 antibody prior to inhalation of P. aeruginosa does not affect plasma creatinine concentrations 24 after inhalation.
*Po0.05.
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FA-induced AKI
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Pneumonia-induced AKI
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Figure 7 |Pneumonia-induced acute kidney injury (AKI) is associated with brush-border defects in renal tubular cells. (a) Periodic
acid-Schiff staining reveals brush-border defects in renal tubular epithelial cells after inhalation of Pseudomonas aeruginosa, as well as
after (b) folic acid (FA) injections. (c) Terminal deoxynucleotidyl transferase 20-deoxyuridine 50-triphosphate nick-end labeling (TUNEL)
staining only reveals very few and weak apoptotic changes in the kidney after inhalation of P. aeruginosa. (d) FA injections lead to massive
apoptosis in renal tubular epithelial cells, as demonstrated by positive TUNEL staining.
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Figure 8 |Pneumonia-induced acute kidney injury is platelet dependent. Compared with control treatment, platelet-depletion before
inhalation of Pseudomonas aeruginosa worsens (a) oxygenation and (b) bacterial load in lung homogenates. (c) Despite worsening
pneumonia, platelet-depleted mice display better kidney function than mice treated with control serum, as shown by significantly lower
plasma creatinine concentrations. CFU, colony-forming unit; PLT, platelet. # indicate Po0.05 versus sham inhalation and * indicate Po0.05
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load during pneumonia, to further impair oxygenation, and
to ultimately worsen pneumonia. We were able to reproduce
these findings in a clinically relevant model of myohemoglo-
binuric AKI and thereby further substantiate the general
concept of AKI-impaired neutrophil recruitment into the
inflamed lung.
Our findings confirm recent studies showing that
neutrophils and their recruitment control development and
severity of bacterial ALI (P. aeruginosa pneumonia).7,26
As outlined earlier, there is experimental evidence to
substantiate the concept of AKI-induced inflammation in the
healthy lung.3,9,27–30 We have also observed a nonsigni-
ficant, slight increase in pulmonary neutrophil content in
mice with isolated AKI (group 2). We observed similar
changes for plasma IL-6 level after induction of AKI. This
is in contrast to other mouse models of AKI, such as
ischemia–reperfusion and bilateral nephrectomy. However,
these models require major abdominal or retroperitoneal
surgery, which by themselves could explain the elevated levels
of IL-6.3,4
In models of bilateral nephrectomy and renal ischemia–
reperfusion, we could not find signs of impaired oxygenation
or significant pulmonary edema.10 In contrast, both our
previous study10 and our current study suggest that AKI
exerts a strong anti-inflammatory and clinically relevant
effect on the injured lung. We have previously demonstrated
in two different murine models of AKI combined with aseptic
ALI that uremic neutrophils fail to recruit into the inflamed
lung and thereby protect from ALI.10 These effects appeared
to depend solely on uremic neutrophils and occurred in both
normal and uremic milieus.10 In our current study, we
provide further evidence to support the idea of AKI-induced
inhibition of pulmonary neutrophil recruitment. Preexisting
AKI attenuates neutrophil recruitment into the lung after
inhalation of P. aeruginosa. Similar to neutrophil-depleted
mice, mice with preexisting AKI display worse oxygenation
and higher bacterial load after inhalation of P. aeruginosa
compared with mice without AKI. Moreover, neutrophils
from mice with FA-induced AKI also demonstrated sig-
nificantly impaired transmigration and F-actin polymeriza-
tion in vitro. Combining our previous results and these
findings, we postulate that AKI-induced inhibition of
neutrophil recruitment gives rise to clinically relevant
aggravation of bacterial ALI with worse oxygenation and
higher bacterial load.
Although our previous findings suggest that the observed
effects depend directly on neutrophils, rather than on soluble
factors, we could not find changes in the expression
of neutrophil surface molecules such as L-selectin (data not
shown). We therefore focused on intracellular events
controlling neutrophil recruitment. Directed neutrophil
migration depends on the coordinated rearrangement of
cytoskeleton structures that provide both protrusion and
contraction. Actin filaments polymerize at the leading edge,
generating a protrusive leading edge that pushes the cell
forward. Contraction occurs through the assembly of
actomyosin filaments along the main body and at the tail,
suppressing lateral protrusions but enabling protrusions at
the leading edge.31–33 Our data show that neutrophils from
mice with FA-induced AKI have a substantial transmigration
defect. Moreover, these neutrophils cannot limit F-actin
formation. As a single and restricted lamellipodia is essential
for directed migration,32,34 the defective migration of neutro-
phils from mice with FA-induced AKI seen in our transwell
assays may be attributed to abnormal cytoskeleton regulation.
Available data allow us to hypothesize that the effect of
AKI on pulmonary neutrophil recruitment depends on the
condition of the lung. Under non-inflammatory conditions,
mechanisms causing AKI or AKI itself appear to have remote,
proinflammatory effects on the lung that can enhance
neutrophil recruitment. AKI, nevertheless, does not promote
neutrophil recruitment during pulmonary inflammation,
which inherently triggers neutrophil recruitment into the
lung. Here, AKI exerts anti-inflammatory effects toward
neutrophils and ultimately inhibits neutrophil recruitment.
Histological signs of less pulmonary inflammation in mice
with pneumonia plus AKI compared with those with only
pneumonia further add to the notion of AKI-induced anti-
inflammatory effects. Neutrophil recruitment itself can
trigger excessive inflammatory responses in the affected
tissue. Thus, a lack of neutrophil recruitment can lead to
attenuated tissue inflammation.35 Moreover, these findings
also allow us to hypothesize that pulmonary damage through
P. aeruginosa itself, for example, via exotoxins,36 has a greater
role under these conditions than damage caused by
neutrophil-dependent pulmonary inflammation per se.
Findings from a recent study about kidney–lung interac-
tion during AKI and ventilation-induced lung injury also
support a differential concept regarding pulmonary neutro-
phil recruitment during AKI.37 In the setting of high tidal
volume ventilation, which in itself causes lung inflammation,
AKI impaired pulmonary neutrophil recruitment into the
lung. Under less inflammatory conditions, for example, low
tidal volume ventilation or spontaneous breathing, these
effects were not observed.
Finally, as neutrophils and their recruitment represent the
body’s the first-line defense against infections,35 our experi-
mental findings also have the potential to explain several
clinical observations. For example, patients with AKI more
frequently develop bacteremia and poor outcome in the
setting of peritonitis, hematologic malignancies, and after
cardiac surgery than patients without AKI.38–41
Various mechanisms have been attributed to ALI-induced
AKI. Mostly, mechanisms of injury have been considered a
consequence of mechanical ventilation, including a reduction
in cardiac output, redistribution of renal blood flow, and
stimulation of hormonal and sympathetic pathways.13 Recent
animal data suggest that maintenance of stable hemody-
namics and alveolar ventilation are crucial in preserving renal
function in the setting of ALI.42 Mechanical ventilation also
induces apoptosis in tubular epithelial cells,17 as well as a
so-called biotrauma.12,16
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We here provide further evidence that bacterial ALI
(pneumonia) itself, without underlying mechanical ventilation,
can cause remote organ injury. Here, pneumonia leads to AKI
within 24 h, as evidenced by corresponding changes in plasma
creatinine and cystatin C concentrations. Pneumonia-induced
AKI appears to be due to direct tubular damage rather than by
pre-renal factors, as evidenced by the significantly increased
neutrophil gelatinase-associated lipocalin concentrations and
stable pulse distension. Moreover, direct bacterial damage to
the kidney is also unlikely, as only a small number of mice had
blood cultures positive for P. aeruginosa, and we could not find
histological evidence of bacterial invasion into the kidneys.
Previously unrecognized as mediators of remote organ
failure, here, platelets have emerged as crucial for the
development of pneumonia-induced AKI. Despite worsening
pneumonia, platelet-depleted mice showed nearly normal
plasma creatinine concentrations. Platelet and platelet-derived
microparticles represent well-known prognostic factors for the
severity of septic organ failure.43,44 Nevertheless, whether
platelets themselves or platelet-derived microparticles or both
are responsible for this effect, requires further studies.
Our study reveals clinically relevant kidney–lung interac-
tions in a murine model of bacterial pneumonia combined
with AKI. Our data further substantiate the notion of AKI-
induced inhibition of neutrophil recruitment, which trans-
lates into higher bacterial load and worse oxygenation in the
setting of bacterial pneumonia. Impaired neutrophil recruit-
ment during AKI seems, at least partially, to be due to altered
cytoskeleton arrangement. On the other hand, bacterial
pneumonia causes AKI in a platelet-dependent manner.
MATERIALS AND METHODS
Animals
The Animal Care and Use Committee of the University of Pittsburgh
approved all animal experiments. We used 10- to 12-week-old wild-
type C57BL/6 mice. Mice were housed in a barrier facility under
specific pathogen-free conditions.
FA-induced AKI
Intraperitoneal injections of FA (450 mg/kg dissolved in NaHCO3)
served to induce AKI (time¼ 0 h, Figure 1).45,46 We have identified
this dose of FA in pilot studies, such that plasma creatinine levels
rose significantly, but without FA, leading to severe illness or death.
Control animals received an equivalent volume of NaHCO3
intraperitonially. We measured plasma creatinine and cystatin C to
assess renal function, using commercially available assays. We also
used commercially available assays to measure plasma levels of IL-6.
Glycerol-induced myohemoglobinuric AKI
Following previously published models of glycerol-induced
myohemoglobinuric AKI,19,20,47 we injected mice intramuscularly
with glycerol (5 ml/kg or normal saline (control). We measured
plasma creatinine and cystatin C to assess renal function, using
commercially available assays.
P. aeruginosa-induced pneumonia
We used inhalation of P. aeruginosa strain UI-18 (PA-7) to induce
pneumonia.7
For each induction cycle, a total of four mice were placed in an
inhalation chamber.48 Two mice had undergone AKI induction 24 h
earlier, and the other two mice had received control treatments 24 h
earlier (time¼ 24 h, Figure 1). A volume of 5 ml of bacteria suspension
(1014 colony-forming units/ml in 0.9% NaCl) or 5 ml of 0.9% NaCl
(sham) was aerosolized over 30 min, after which the mice were removed
from the chamber. At 24 h after inhalation (time¼ 48 h, Figure 1), we
measured oxygen saturation and pulse distension in unanesthetized
mice, using a small-animal pulse oximeter.22,23 Mice were then
anesthetized to obtain blood samples through puncture of the inferior
vena cava and to harvest lungs and kidneys for further analyses.
Induction of AKI and subsequent pneumonia, together with
respective control experiments, resulted in a maximum of four
different experimental groups (Figure 1): mice with control injection
and sham inhalation (group 1), mice with AKI and sham inhalation
(group 2), mice with control injection and pneumonia (group 3),
and mice with AKI and pneumonia (group 4).
A subgroup of mice received either neutrophil-depleting anti-
body (a-GR-1, clone RB6–8C5) or anti-platelet serum (Accurate
Chemicals, Westbury, NY) before inhalation to assess the role of
neutrophils and platelets in our pneumonia model, respectively.8,10
In previous studies, this sufficiently depleted circulating neutrophils
or platelets but did not affect other cell counts.10,49 When compared
with a control antibody, injection of a neutrophil-depleting
antibody significantly decreased the number of circulating neutro-
phils (mean±s.d.: 136±86 versus 2000±217/ml) but did not affect
the number mononuclear cells. Similarly, pretreatment with
antiplatelet serum significantly decreased the number of circulating
platelets (mean±s.d.: 313±47 1000/ml versus 681±65 1000/ml)
without altering white cell counts.
Tissue MPO activity
To determine global neutrophil content in both kidneys and lungs,
we measured tissue MPO activity according to our previously
published protocol.10,49 We have shown earlier49 that changes in
MPO represent an excellent indicator of global tissue neutrophil
recruitment.
Histological evaluation
Lungs were inflation-fixed by means of tracheal instillation of 2 zinc
fixative. Kidneys and lungs were then excised and embedded in paraffin.
Hematoxylin and eosin stain. Tissue sections (5 mm) were cut
and stained with hematoxylin and eosin under standard techniques.
Terminal deoxynucleotidyl transferase 20-deoxyuridine
50-triphosphate nick-end labeling stain. Slides were digested with
20 mg/ml proteinase K and quenched with H2O2. Slides were then
stained with ApoTag Peroxidase Kit (Millipore, Billerica, MA)
according to the manufacturer’s instructions. Finally, slides were
stained with DAB, washed, counterstained with aqueous hematox-
ylin, and blued in Scott’s tap water substitute.
Periodic acid-Schiff stain. Slides were soaked in periodic acid
and rinsed in distilled H2O. Slides were then soaked in Schiff ’s
reagent, washed in running tap water, and counterstained with Gill
No. 3 Hematoxylin (Sigma-Aldrich, St Louis, MO).
Blood and lung P. aeruginosa colony-forming unit
At the time of killing, blood samples were collected and lungs were
removed aseptically and placed in 3 ml of sterile saline each. The lungs
were then homogenized with a tissue homogenizer under a vented
hood. Serial 1:10 dilutions of both blood samples and lung
homogenates were prepared. A volume of 100ml of each dilution was
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plated on Pseudomonas isolation agar plates; the plates were incubated
for 18 h at 37 1C, and then the number of colonies were counted.
Neutrophil isolation
Neutrophils were isolated from bone marrow cells by Percoll
gradient as previously described.50
Transwell migration assays
As described recently,50 migration was evaluated using 3mm transwell
chambers coated with fibrinogen in chemotaxis assay. Migration
without fMLP or toward fMLP was allowed for 3 h. The migrated cells
in the bottom well were counted with a hemocytometer.
F-actin structures
To examine F-actin structures, we followed our recently published
protocol.50 Briefly, neutrophils (5 104) were prestimulated with
fMLP and placed on fibrinogen-coated slides for 0 and 10 min at
37 1C. The cells were fixed, permeabilized with 0.1% Triton X-100,
and stained with rhodamine-labeled phalloidin.
Z series of fluorescence images were captured using a
Leica DMI6000 fluorescence microscope (Leica Microsystems,
Buffalo Grove, IL) at 63/1.3 NA objective, with ORCA-ER C4742-
95 camera (Hamamatsu, Bridgewater, NJ) driven by Openlab
software (Openlab, Florence, Italy). Z series were analyzed by
deconvolution using Volocity software (Perkin Elmer, Waltham,
MA). Quantifications were performed using region measurement in
Openlab software.50
Statistical analysis
All data are presented as median (interquartile range). Statistical
analysis included Shapiro–Wilks test for normality, one-way analysis of
variance, Kruskal–Wallis one-way analysis of variance, post-hoc
Student–Newman–Keuls test, t-test, Mann–Whitney U test, and Fisher’s
exact test (Po0.05 was considered statistically significant). N¼ 5–14
mice for all experiments.
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